Mr Learner, there has been no improvement from management yet the product is speaking for itself.I have no doubts in the near future it will spike but that is not what we are here for.It needs consistency and well written reports to substantiate the SP going forward.I trust you are well at the moment and stay safe.
Ann: ANP Submits US Orphan Drug application for ATL1102 in DMD, page-61
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.8¢ |
Change
0.001(1.30%) |
Mkt cap ! $70.32M | |||
| Open | High | Low | Value | Volume |
| 7.7¢ | 7.9¢ | 7.6¢ | $139.5K | 1.774M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 170566 | 7.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 1471 | 1 |
View Market Depth
| Last trade - 13.42pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.8¢ |
Change
0.001 ( 2.63 %) |
||||
| Open | High | Low | Volume | ||
| 7.7¢ | 7.9¢ | 7.7¢ | 43057 | ||
| Last updated 13.04pm 03/05/2024 ? | |||||
| PER (ASX) Chart |